Arena launched with $500 million in early 2024 to fund basic biological research, from which it planned to spin out dedicated ...
Harmony Biosciences has paused a mid-stage trial of ZYN002 in 22q11.2 deletion syndrome after the THC-free cannabinoid drug ...
As Novo Nordisk and Pfizer fight over a promising GLP-1 pipeline at Metsera, Amgen is staying the course on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results